Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-13.48	-2172.72	-1914.57
Graham Fair Price	3.73	13.12	12.65
PEG	215.40	1.21	-0.38
Price/Book	11.61	0.96	0.86
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	7.04	8.04	7.51
Price/Sales	5.04	9.09	8.66
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	13.09	-0.01	-0.01
ROA	-3.59	< 0.005	< 0.005
ROE	0.03	0.03	4.26
ROIC	< 0.005	< 0.005	13.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.03	31.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.02	0.10	-89.94
EPS QOQ	-0.20	0.07	-66.06
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	-0.07	0.03	-56.60
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	13.88	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.76	0.77	1.70
Quick Ratio	0.20	0.24	20.76
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.80	16.05	1.59
Cash	37.58	43.16	14.85
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	1.56	1.69	7.94
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.23	0.28	21.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1225.96	-1340.46	-9.34
Naive Interpretation	Member

06 - Financial Health · Bad

Rating